MDXH.BR
MDxHealth SA
Price:  
3.02 
EUR
Volume:  
14,079.00
Belgium | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

MDXH.BR WACC - Weighted Average Cost of Capital

The WACC of MDxHealth SA (MDXH.BR) is 5.6%.

The Cost of Equity of MDxHealth SA (MDXH.BR) is 6.40%.
The Cost of Debt of MDxHealth SA (MDXH.BR) is 5.00%.

Range Selected
Cost of equity 4.60% - 8.20% 6.40%
Tax rate 25.00% - 25.00% 25.00%
Cost of debt 5.00% - 5.00% 5.00%
WACC 4.3% - 6.8% 5.6%
WACC

MDXH.BR WACC calculation

Category Low High
Long-term bond rate 3.2% 3.7%
Equity market risk premium 6.4% 7.4%
Adjusted beta 0.13 0.47
Additional risk adjustments 0.5% 1.0%
Cost of equity 4.60% 8.20%
Tax rate 25.00% 25.00%
Debt/Equity ratio 0.44 0.44
Cost of debt 5.00% 5.00%
After-tax WACC 4.3% 6.8%
Selected WACC 5.6%

MDXH.BR's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for MDXH.BR:

cost_of_equity (6.40%) = risk_free_rate (3.45%) + equity_risk_premium (6.90%) * adjusted_beta (0.13) + risk_adjustments (0.75%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.